Lion Biotechnologies to Present at the 4th Annual Cancer Immunotherapy Conference
March 24, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 24, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
Lion Biotechnologies to Present at the BioCentury Future Leaders Conference
March 21, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 21, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
Lion Biotechnologies to Present at the 26th Annual ROTH Conference
March 04, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, March 4, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO) announced that Chief Executive Officer Manish Singh, Ph.D., will present at the 26th Annual ROTH Conference on...
Lion Biotechnologies Issues Letter to Shareholders
February 03, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO) announced that Chairman and CEO, Manish Singh, Ph.D., has issued the following letter to the shareholders.
Dear...